Achieved High Quality Revenue Growth with Sustained Operating Leverage More Than Doubled Share Repurchaseto Approximately HKD112bn
FREMONT,Calif.,March 19,2025-- Alamar Biosciences,a company powering precision proteomics to enable the earliest detection of disease,is pleased to announce the signing of five new distribution partne
SAN JOSE,Calif.,March 19,2025-- MSI,a global leader in AI computing,high-performance server solutions,and intelligent automation,will showcase its latest AI-powered Autonomous Mobile Robots (AMRs) and
SHANGHAI,March 19,2025-- Xiao-I Corporation (NASDAQ: AIXI),an advanced artificial intelligence company ("Xiao-I"),announced a global strategic partnership with TF International Securities Gr
BEIJING,SHANGHAI and BOSTON,March 19,2025-- Jacobio Pharma (1167.HK) released its 2024 annual results,with revenue of RMB160million,R&D expense of RMB330 million. Major operating and financing act
Investment reinforces confidence in Funding Societies\' decade-long mission amid market volatility and underscores commitment to financial inclusion for underserved businesses
